Fox Rothschild's Mark Wagner on why scaling drug production is so slow — overseas API sourcing, supplier qualification, and ...
PaxSafe's Mark Talens on why pharma supply chain AI fails before it starts — and the data foundry framework that changes that. Pharmaceutical Executive spoke with Mark Talens, CCO of PAXAFE at ...
Thomas Appio has been named interim CEO of Bausch + Lomb, a move coinciding with an expected upward revision to the company’s ...
If AI is taking over the routine assignments that have traditionally supported an apprenticeship model, through which new ...
Pharmaceutical Executive spoke with Mark Talens, CCO of PAXAFE at LogiPharma 2026 in Boston. During the conversation., the ...
Drug shortages remain a difficult to fix issue for the pharma industry and are an issue that can have devastating results.
Tukysa adds a chemotherapy-free maintenance option for HER2-positive metastatic breast cancer; liver toxicity monitoring ...
Fox Rothschild's Mark Wagner on why scaling drug production is so slow — overseas API sourcing, supplier qualification, and FDA site approvals that take years. Fox Rothschild's Mark Wagner on why the ...
Caribou Biosciences discontinues its two allogeneic CAR-T programs, Kamal Biswas makes the case for continuous quality ...
Adding artificial intelligence (AI) to legacy pharma supply chain systems requires auditable human intelligence to fix data ...
The FDA approves Roche’s Tecentriq for a subset of colon cancer patients, TRexBio and Retension Pharmaceuticals price new ...
Pharmaceutical Executive spoke with Mark Talens, CCO of PAXAFE at LogiPharma 2026 in Boston. During the conversation., the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results